Induction Immunosuppressive Therapy Use in Deceased Donor Kidney Transplantation: 11-Year Experience in Veracruz, Mexico.
暂无分享,去创建一个
G. Martínez-Mier | M. Trujillo-Martínez | L. Budar-Fernández | M. T. Méndez-López | E. Soto-Miranda | S. F. Ávila-Pardo | L. J. Mateu-Rivera | A. Uscanga-Montesano | D. Avila Y Falfan
[1] T. Srinivas,et al. Prospective Randomized Controlled Trial of Rabbit Antithymocyte Globulin Compared With IL-2 Receptor Antagonist Induction Therapy in Kidney Transplantation , 2014, Annals of surgery.
[2] A. Bagul,et al. Thymoglobulin and Its Use in Renal Transplantation: A Review , 2013, American Journal of Nephrology.
[3] G. S. Silva Júnior,et al. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin. , 2011, International immunopharmacology.
[4] Spencer T. Martin,et al. Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal , 2011, Pharmacotherapy.
[5] Ethan M Balk,et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. , 2010, Kidney international.
[6] A. Webster,et al. Interleukin 2 receptor antagonists for kidney transplant recipients. , 2010, The Cochrane database of systematic reviews.
[7] J. Squifflet,et al. Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. , 2009, Journal of the American Society of Nephrology : JASN.
[8] M. Schnitzler,et al. Early Outcomes of Thymoglobulin and Basiliximab Induction in Kidney Transplantation: Application of Statistical Approaches to Reduce Bias in Observational Comparisons , 2009, Transplantation.
[9] D. Brennan,et al. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. , 2006, The New England journal of medicine.